Prolotherapy vs. Extracorporeal Shock Wave Therapy in Chronic Plantar Fasciitis
Comparison of Ultrasound-Guided Prolotherapy Versus Extracorporeal Shock Wave Therapy in the Treatment of Chronic Plantar Fasciitis: A Randomized Clinical Trial.J Foot Ankle Surg . Jan-Feb 2022;61(1):48-52.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Twenty nine patients with chronic plantar fasciitis were randomized to receive extracorporeal shockwave therapy (ESWT, n=15) or dextrose prolotherapy (n=15). Outcomes of interest included pain measured using a visual analogue scale (VAS) and function measured with the Roles and Maudsley Scale score (RMS) and the Foot Function Index (FFI). Both groups demonstrated significant improvements in pain a...
Join the Conversation
Please Login or Join to leave comments.